Analysis of flt3 gene mutations and expression in myelodysplastic syndromes (MDS).

被引：0
|
作者：
Papageorgiou, S [1 ]
Pappa, V [1 ]
Economopoulos, T [1 ]
Papageorgiou, E [1 ]
Dervenoulas, J [1 ]
Mantzios, G [1 ]
Kontsioti, F [1 ]
Valsami, S [1 ]
Raptis, S [1 ]
机构：
[1] Univ Athens, Evangelismos Hosp, Dept Internal Med 2, Athens, Greece
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1497
引用
收藏
页码：355A / 356A
页数：2
相关论文
共 50 条
  • [1] FLT3 mutations in myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML)
    Bhamidipati, Pavan Kumar
    Daver, Naval Guastad
    Kantarjian, Hagop
    Pierce, Sherry
    Daver, Roshni
    Cortes, Jorge E.
    Ravandi, Farhad
    Mathisen, Michael
    Pemmaraju, Naveen
    Nazha, Aziz
    Kadia, Tapan M.
    Jabbour, Elias
    Borthakur, Gautam
    Faderl, Stefan
    Garcia-Manero, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Detection of FLT3 gene mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)
    Andrei, A.
    Crisan, D.
    Meng, X.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (05): : 639 - 639
  • [3] Analysis of FLT3 gene mutations in de novo myelodysplastic syndromes.: FLT3 internal tandem duplication detected in a case of refractory anemia
    Pappa, Vassiliki
    Papageorgiou, Sotirios
    Kontsioti, Frieda
    Papageorgiou, Efstathios
    Tsiotra, Panayioula
    Dervenoulas, John
    Economopoulos, Theofanis
    LEUKEMIA & LYMPHOMA, 2007, 48 (12) : 2437 - 2440
  • [4] Different Roles of NPM1 and FLT3 Mutations in Myelodysplastic Syndromes
    Bains, A.
    Luthra, R.
    Medeiros, L. J.
    Zuo, Z.
    MODERN PATHOLOGY, 2010, 23 : 286A - 286A
  • [5] FLT3 expression as a marker of progression and response to treatment in myelodysplastic syndromes
    Bernasconi, P.
    Calatroni, S.
    Rocca, B.
    Boni, M.
    Cavigliano, P. M.
    Giardini, I.
    Zappatore, R.
    Dambruoso, I.
    Caresana, M.
    Astori, C.
    Castagnola, C.
    Lazzarino, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 234 - 234
  • [6] Different Roles of NPM1 and FLT3 Mutations in Myelodysplastic Syndromes
    Bains, A.
    Luthra, R.
    Medeiros, L. J.
    Zuo, Z.
    LABORATORY INVESTIGATION, 2010, 90 : 286A - 286A
  • [7] TERT Gene Promoter Mutations In Myelodysplastic Syndromes (MDS)
    Matteucci, Caterina
    Iannotti, Tamara
    Brandimarte, Lucia
    Nofrini, Valeria
    Barba, Gianluca
    Sgura, Antonella
    Berardinelli, Francesco
    Nozza, Filomena
    Di Battista, Valeria
    Mecucci, Cristina
    BLOOD, 2013, 122 (21)
  • [8] FLT3 Inhibitor Therapy for Patients with Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML): Impact On Survival According to FLT3 Status.
    Pemmaraju, Naveen
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Gautam, Borthakur
    Parikh, Sameer A.
    Konopleva, Marina
    Kornblau, Steven M.
    Andreeff, Michael
    O'Brien, Susan
    Cones, Jorge
    BLOOD, 2009, 114 (22) : 424 - 425
  • [9] FLT3 gene mutations in AML
    Mills, KI
    Gilkes, AF
    Walsh, V
    Sweeney, M
    Austin, SJ
    Gale, RE
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 29 - 29
  • [10] Mutations of myelodysplastic syndromes (MDS): An update
    Ganguly, Bani Bandana
    Kadam, N. N.
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2016, 769 : 47 - 62
12345